WRNIP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.555600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.033800E-01
Normal-vs-Stage2
6.534500E-02
Normal-vs-Stage3
4.041600E-01
Normal-vs-Stage4
6.654400E-02
Stage1-vs-Stage2
5.606000E-01
Stage1-vs-Stage3
1.243760E-01
Stage1-vs-Stage4
2.073000E-01
Stage2-vs-Stage3
1.253190E-01
Stage2-vs-Stage4
6.903800E-02
Stage3-vs-Stage4
5.091600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.284000E-03
Normal-vs-AfricanAmerican
5.247200E-01
Normal-vs-Asian
9.472000E-01
Caucasian-vs-AfricanAmerican
2.435600E-01
Caucasian-vs-Asian
2.924800E-01
AfricanAmerican-vs-Asian
6.771400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.592330E-02
Normal-vs-Female
4.186500E-02
Male-vs-Female
8.176600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.085400E-01
Normal-vs-Age(41-60Yrs)
1.636840E-03
Normal-vs-Age(61-80Yrs)
1.037640E-01
Normal-vs-Age(81-100Yrs)
1.900970E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.570000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.937200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.255600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.789230E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.653600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.788400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.434200E-01
Normal-vs-Daily Drinker
4.993600E-01
Normal-vs-Weekly Drinker
7.981200E-01
Normal-vs-Occasional Drinker
9.781400E-03
Normal-vs-Social Drinker
4.279600E-01
Non Drinker-vs-Daily Drinker
9.453600E-01
Non Drinker-vs-Weekly Drinker
8.174200E-01
Non Drinker-vs-Occasional Drinker
2.450000E-02
Non Drinker-vs-Social Drinker
6.222400E-01
Daily Drinker-vs-Weekly Drinker
8.569200E-01
Daily Drinker-vs-Occasional Drinker
2.251700E-02
Daily Drinker-vs-Social Drinker
5.438000E-01
Weekly Drinker-vs-Occasional Drinker
2.568300E-02
Weekly Drinker-vs-Social Drinker
5.091200E-01
Occasional Drinker-vs-Social Drinker
4.169900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.230400E-01
Normal-vs-Grade 2
4.882500E-03
Normal-vs-Grade 3
3.269800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.419000E-01
Grade 1-vs-Grade 3
9.424600E-01
Grade 1-vs-Grade 4
1.230400E-01
Grade 2-vs-Grade 3
9.985500E-02
Grade 2-vs-Grade 4
4.882500E-03
Grade 3-vs-Grade 4
3.269800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.191200E-01
Normal-vs-NonDiabetic
5.578400E-03
Diabetic-vs-NonDiabetic
2.689400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.719200E-01
Normal-vs-NoPancreatitis
1.988240E-02
Pancreatitis-vs-NoPancreatitis
8.542600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.859200E-03
Normal-vs-N1
7.392100E-02
N0-vs-N1
8.202100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.844500E-03
Normal-vs-TP53-NonMutant
1.708220E-01
TP53-Mutant-vs-TP53-NonMutant
3.988100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
